What is it used for?
OPDUALAG™ is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.OPDUALAG™ is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- nivolumab and relatlimabnivolumab and relatlimab
- Form and strength
- INJECTION · 12 mg / 1 mL · 4 mg / 1 mLINJECTION · 12 mg / 1 mL · 4 mg / 1 mL
- Manufacturer / applicant
- E.R. SQUIBB & SONS, L.L.C.E.R. SQUIBB & SONS, L.L.C.
Injection: 240 mg nivolumab and 80 mg relatlimab per 20 mL (12 mg and 4 mg per mL) as a clear to opalescent, colorless to slightly yellow solution in a single-dose vial.Injection: 240 mg nivolumab and 80 mg relatlimab per 20 mL (12 mg and 4 mg per mL) as a clear to opalescent, colorless to slightly yellow solution in a single-dose vial.
Safety and clinical review
- Severe and Fatal Immune-Mediated Adverse ReactionsSevere and Fatal Immune-Mediated Adverse Reactions
- Immune-Mediated PneumonitisImmune-Mediated Pneumonitis
- Immune-Mediated ColitisImmune-Mediated Colitis
- Immune-Mediated HepatitisImmune-Mediated Hepatitis
- Immune-Mediated EndocrinopathiesImmune-Mediated Endocrinopathies
- Immune-Mediated Nephritis with Renal DysfunctionImmune-Mediated Nephritis with Renal Dysfunction
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Opdualag used for?
OPDUALAG™ is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.OPDUALAG™ is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Opdualag should I ask about?
INJECTION · 12 mg / 1 mL · 4 mg / 1 mLINJECTION · 12 mg / 1 mL · 4 mg / 1 mL
Read the primary sourceWhat determines the price of Opdualag?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Opdualag?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.